Interleukin-7 and Suppression of Local Peritoneal Immunity in Ovarian Carcinoma
X Xie,D Ye,H Chen,W Lu,B Cheng,H Zhong
DOI: https://doi.org/10.1016/j.ijgo.2003.08.015
2003-01-01
International Journal of Gynecology & Obstetrics
Abstract:Objectives: To investigate the epithelial ovarian carcinoma (EOC) secretion of interleukin-7 (IL-7). Methods: Levels of IL-7 were assayed by enzyme-linked immunoadsorbent assay and IL-7 mRNA, and protein expression in tissues and cell lines were detected by RT-PCR and immunohistochemistry. Results: The median serum IL-7 level in patients with EOC (32 cases; 32.49 pg/ml) was significantly higher than that of patients with benign tumors (16 cases; 7.59 pg/ml) and healthy women (16 cases; 10.64 pg/ml) (P<0.05). The median peritoneal fluid IL-7 level in patients with EOC (17.39 pg/ml) was slightly higher than that of patients with benign tumors (14.09 pg/ml), but not significantly so (P>0.05). There were positive correlations between the serum and peritoneal fluid IL-7 levels in both ovarian cancer and benign group (P<0.05, both). Only two EOC specimens expressed IL-7 mRNA, and no IL-7 protein positive was found in any specimens. Conclusions: Epithelial ovarian carcinoma cells rarely express IL-7, and IL-7 levels are decreased in the ascitic fluid of patients with EOC.
What problem does this paper attempt to address?